Guggenheim Capital LLC Verona Pharma PLC Transaction History
Guggenheim Capital LLC
- $13.3 Billion
- Q3 2025
A detailed history of Guggenheim Capital LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Guggenheim Capital LLC holds 4,708 shares of VRNA stock, worth $503,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,708Holding current value
$503,332% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
241Shares Held
78.3MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Ubs Oconnor LLC Chicago, IL4.28MShares$458 Million27.57% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...